title: Dacryoadenitis associated with subcutaneous Sweet's syndrome in a patient with acute myeloid leukemia.
abstract: A 26-year-old woman presented with a painful skin eruption which led to the diagnosis of acute myeloid leukemia. During chemotherapy, she developed an unusual orbital inflammation. Careful observation of the clinical course, computed tomography, and orbital biopsy were necessary to establish the diagnosis of dacryoadenitis associated with subcutaneous Sweet's syndrome. The skin eruption and the dacryoadenitis resolved rapidly with corticosteroid therapy. This is the first report of dacryoadenitis in the course of subcutaneous Sweet's syndrome.
authors.affiliation: Department of Ophthalmology, Centre Hospitalier Universitaire, CHU-Nancy, France. t.maalouf@chu-nancy.fr
authors.forename: Toufic
authors.initials: T
authors.lastname: Maalouf
authors.forename: Karine
authors.initials: K
authors.lastname: Angioi
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ssi-Yan-Kai
authors.forename: Frederic
authors.initials: F
authors.lastname: Vernerey
authors.forename: Brigitte
authors.initials: B
authors.lastname: Witz
authors.forename: Jean
authors.initials: J
authors.lastname: George
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001707:Biopsy, Needle; D003607:Dacryocystitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D018570:Risk Assessment; D012720:Severity of Illness Index; D040521:Subcutaneous Tissue / Q000473:pathology; D016463:Sweet Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones